SOPHiA GENETICS Releases 2024 ESG Impact Summary

TL;DR

SOPHIA GENETICS dropped its 2024 ESG report, check IR for deets.

AI Summary

SOPHiA GENETICS SA filed a Form 6-K on May 16, 2025, to announce the publication of its 2024 Environmental, Social and Governance (ESG) Impact Summary. This summary, reflecting data as of December 31, 2024, is available on the company's investor relations website.

Why It Matters

This filing provides stakeholders with insights into SOPHiA GENETICS' commitment to sustainability and corporate responsibility, which can influence investor decisions and company valuation.

Risk Assessment

Risk Level: low — The filing is an informational update regarding an ESG report and does not contain significant financial or operational news that would typically increase risk.

Key Players & Entities

• SOPHiA GENETICS SA (company) — Registrant
• Daan van Well (person) — Chief Legal and Regulatory Officer
• 2024 ESG Impact Summary (document) — Published report

FAQ

From the Filing

0001840706-25-000018.txt : 20250516 0001840706-25-000018.hdr.sgml : 20250516 20250516095325 ACCESSION NUMBER: 0001840706-25-000018 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20250516 FILED AS OF DATE: 20250516 DATE AS OF CHANGE: 20250516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOPHiA GENETICS SA CENTRAL INDEX KEY: 0001840706 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40627 FILM NUMBER: 25957212 BUSINESS ADDRESS: STREET 1: LA PIECE, CH-1180 CITY: ROLLE STATE: V8 ZIP: 00000 BUSINESS PHONE: 41 21 694 10 60 MAIL ADDRESS: STREET 1: LA PIECE, CH-1180 CITY: ROLLE STATE: V8 ZIP: 00000 6-K 1 esg2024sophiageneticssa6-k.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. ____________________________________ Commission File Number: 001-40627 SOPHiA GENETICS SA (Exact name of registrant as specified in its charter) La Pièce 12 CH-1180 Rolle Switzerland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F x Form 40-F SIGNATURE SOPHiA GENETICS SA (the “Company”) today published its Environmental, Social and Governance Impact Summary as per December 31, 2024 (“2024 ESG Impact Summary”). The 2024 ESG Impact Summary is available on www.sophiagenetics.com, in the Investor Relations section. SOPHiA GENETICS SA Date: May 16, 2025 By: /s/ Daan van Well Name: Daan van Well Title: Chief Legal and Regulatory Officer EXHIBIT INDEX Exhibit No. Description 99.1 2024 ESG Impact Summary EX-99.1 2 a2024sgesgimpactsummary.htm EX-99.1 a2024sgesgimpactsummary Democratizing Data-Driven Medicine, Together ESG Impact Summary Since our inception, sustainability has been a cornerstone of our mission at SOPHiA GENETICS. Back in 2011, the word “sustainability” was mostly used in an environmental context. But as we built our technology, we saw its relevance to healthcare, and especially to data. From processing to interpretation, we set out to make data use more eicient, minimize waste, and ensure that today’s insights help tomorrow’s patients. Launching our collective intelligence model was just the beginning. As we broadened our perspective, new opportunities for improvement came into view. Producing and interpreting data is resource intensive. That’s why we help our partner laboratories operate their genomic instruments at full capacity: maximizing throughput, reducing the use of single-use plastics, and cutting energy waste from underloaded sequencer runs. Our downstream algorithms are built to handle the resulting data volume, ensuring that environmental gains never come at the expense of analytical performance. Once data is generated, every genomic read and clinical datapoint carries value, and cost. Throwing those assets away would be medically and ecologically wasteful. Our SOPHiA DDM™ platform enables hospitals to compare each new patient’s data against one of the world’s largest federated knowledge bases, continuously learning while sparing the resources needed for redundant tests. As we move forward in the digital age, our next challenge lies in processing and storing data more eiciently. Running in the cloud comes with carbon footprint, but it also avoids the environmental cost of maintaining local servers’ infrastructure. As our data volume grows, we continuously refactor code and improve algorithms. Not just to deliver more precise insights, but also